221 related articles for article (PubMed ID: 17929014)
1. Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems.
Jentzen W; Weise R; Kupferschläger J; Freudenberg L; Brandau W; Bares R; Burchert W; Bockisch A
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):611-23. PubMed ID: 17929014
[TBL] [Abstract][Full Text] [Related]
2. Quantitative performance evaluation of
Wierts R; Jentzen W; Quick HH; Wisselink HJ; Pooters INA; Wildberger JE; Herrmann K; Kemerink GJ; Backes WH; Mottaghy FM
Phys Med Biol; 2017 Dec; 63(1):015014. PubMed ID: 29116052
[TBL] [Abstract][Full Text] [Related]
3. Pre-therapeutic (124)I PET(/CT) dosimetry confirms low average absorbed doses per administered (131)I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer.
Jentzen W; Hobbs RF; Stahl A; Knust J; Sgouros G; Bockisch A
Eur J Nucl Med Mol Imaging; 2010 May; 37(5):884-95. PubMed ID: 20069293
[TBL] [Abstract][Full Text] [Related]
4. Comparison of fluorine-18 and bromine-76 imaging in positron emission tomography.
Ribeiro MJ; Almeida P; Strul D; Ferreira N; Loc'h C; Brulon V; Trébossen R; Mazière B; Bendriem B
Eur J Nucl Med; 1999 Jul; 26(7):758-66. PubMed ID: 10398824
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of small-animal (124)I activity distributions using a clinical PET/CT scanner.
González Trotter DE; Manjeshwar RM; Doss M; Shaller C; Robinson MK; Tandon R; Adams GP; Adler LP
J Nucl Med; 2004 Jul; 45(7):1237-44. PubMed ID: 15235072
[TBL] [Abstract][Full Text] [Related]
6. Whole-remnant and maximum-voxel SPECT/CT dosimetry in
Mínguez P; Flux G; Genollá J; Delgado A; Rodeño E; Sjögreen Gleisner K
Med Phys; 2016 Oct; 43(10):5279-5287. PubMed ID: 28105713
[TBL] [Abstract][Full Text] [Related]
7. Impact of prompt gamma coincidence correction on absorbed dose estimation in differentiated thyroid cancer using 124I PET/CT imaging.
Wierts R; Conti M; Claessen AGG; Herrmann K; Kemerink GJ; Binse I; Wildberger JE; Mottaghy FM; Backes WH; Jentzen W
Nucl Med Commun; 2018 Dec; 39(12):1156-1164. PubMed ID: 30204643
[TBL] [Abstract][Full Text] [Related]
8. Spatial resolution and image qualities of Zr-89 on Siemens Biograph TruePoint PET/CT.
Lee YS; Kim JS; Kim JY; Kim BI; Lim SM; Kim HJ
Cancer Biother Radiopharm; 2015 Feb; 30(1):27-32. PubMed ID: 25549151
[TBL] [Abstract][Full Text] [Related]
9. Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT.
Doot RK; Scheuermann JS; Christian PE; Karp JS; Kinahan PE
Med Phys; 2010 Nov; 37(11):6035-46. PubMed ID: 21158315
[TBL] [Abstract][Full Text] [Related]
10. Phantom validation of coregistration of PET and CT for image-guided radiotherapy.
Lavely WC; Scarfone C; Cevikalp H; Li R; Byrne DW; Cmelak AJ; Dawant B; Price RR; Hallahan DE; Fitzpatrick JM
Med Phys; 2004 May; 31(5):1083-92. PubMed ID: 15191296
[TBL] [Abstract][Full Text] [Related]
11. Effect of motion on tracer activity determination in CT attenuation corrected PET images: a lung phantom study.
Pevsner A; Nehmeh SA; Humm JL; Mageras GS; Erdi YE
Med Phys; 2005 Jul; 32(7):2358-62. PubMed ID: 16121593
[TBL] [Abstract][Full Text] [Related]
12. Two-dimensional vs three-dimensional imaging in whole body oncologic PET/CT: a Discovery-STE phantom and patient study.
Bettinardi V; Mancosu P; Danna M; Giovacchini G; Landoni C; Picchio M; Gilardi MC; Savi A; Castiglioni I; Lecchi M; Fazio F
Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):214-23. PubMed ID: 17464266
[TBL] [Abstract][Full Text] [Related]
13. Acquisition settings for PET of 124I administered simultaneously with therapeutic amounts of 131I.
Lubberink M; van Schie A; de Jong HW; van Dongen GA; Teule GJ
J Nucl Med; 2006 Aug; 47(8):1375-81. PubMed ID: 16883019
[TBL] [Abstract][Full Text] [Related]
14. Impact of Ge-68/Ga-68-based versus CT-based attenuation correction on PET.
van Dalen JA; Visser EP; Vogel WV; Corstens FH; Oyen WJ
Med Phys; 2007 Mar; 34(3):889-97. PubMed ID: 17441234
[TBL] [Abstract][Full Text] [Related]
15. Beyond 18F-FDG: Characterization of PET/CT and PET/MR Scanners for a Comprehensive Set of Positron Emitters of Growing Application--18F, 11C, 89Zr, 124I, 68Ga, and 90Y.
Soderlund AT; Chaal J; Tjio G; Totman JJ; Conti M; Townsend DW
J Nucl Med; 2015 Aug; 56(8):1285-91. PubMed ID: 26135111
[TBL] [Abstract][Full Text] [Related]
16. Quantitative PET comparing gated with nongated acquisitions using a NEMA phantom with respiratory-simulated motion.
Vines DC; Keller H; Hoisak JD; Breen SL
J Nucl Med Technol; 2007 Dec; 35(4):246-51. PubMed ID: 18006594
[TBL] [Abstract][Full Text] [Related]
17. Assessment of errors caused by X-ray scatter and use of contrast medium when using CT-based attenuation correction in PET.
Ay MR; Zaidi H
Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1301-13. PubMed ID: 16622710
[TBL] [Abstract][Full Text] [Related]
18. Segmentation of PET volumes by iterative image thresholding.
Jentzen W; Freudenberg L; Eising EG; Heinze M; Brandau W; Bockisch A
J Nucl Med; 2007 Jan; 48(1):108-14. PubMed ID: 17204706
[TBL] [Abstract][Full Text] [Related]
19. Static and moving phantom studies for radiation treatment planning in a positron emission tomography and computed tomography (PET/CT) system.
Okubo M; Nishimura Y; Nakamatsu K; Okumura M; Shibata T; Kanamori S; Hanaoka K; Hosono M
Ann Nucl Med; 2008 Aug; 22(7):579-86. PubMed ID: 18756360
[TBL] [Abstract][Full Text] [Related]
20. Experimental investigation of factors affecting the absolute recovery coefficients in iodine-124 PET lesion imaging.
Jentzen W
Phys Med Biol; 2010 Apr; 55(8):2365-98. PubMed ID: 20360631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
